Agreement - December 4, 2018
OnDosis and Recipharm enter partnership
Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market. The objective is to develop an improved treatment for both the patient and for healthcare professionals. The new treatment for the management of ADHD […]
CDMO - October 26, 2018
Recipharm continues manufacturing operations in Höganäs
Recipharm announces that it will continue the manufacturing operations at its facility in Höganäs, Sweden, operations that earlier were set towards being discontinued. In 2017, Recipharm announced the intention to discontinue the operations in Höganäs and evaluate different options for the facility, including divestment of the site. During this evaluation, new customers have actively approached […]
Business article - June 13, 2018
Recipharm prepares for Brexit
With less than a year until the UK exits the European Union, the CDMO company has established a taskforce to manage the potential impact of Brexit on its organisation. The formation of the ‘Brexit taskforce’ will see Recipharm prioritize its preparations and invest in the necessary capabilities and equipment within its UK and European facilities […]
Business Award - November 29, 2017
Recipharm awarded for growth in France
Recipharm has received recognition for its commitment to its French operations. The award “le Prix d’Excellence 2017 – Spécial Sciences de la vie” is presented by the Swedish Chamber of Commerce in France. The award is to acknowledge examples of best practice in the Franco-Swedish business community. As part of the application process, Recipharm was assessed on […]
CDMO - November 13, 2017
Recipharm to end operations in two facilities in Sweden
Recipharm has announced that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in Stockholm and Höganäs, Sweden. Since 2015, Recipharm has been implementing efficiency activities in the Swedish part of the business segment known as Solids and Others. These initiatives have included a reduction in headcount and the […]
CDMO - October 24, 2017
Recipharm equips Lisbon facility for US and European serialisation
Recipharm has equipped its sixth facility with serialisation capabilities before the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 million investment into its company-wide implementation programme in 2016. The Lisbon […]
